Daphne Zohar, PureTech CEO
PureTech turns 200-year-old discovery into a new approach to Alzheimer's, while clinging to controversial amyloid hypothesis
Before MRIs or CT scans, 18th-century anatomist Paolo Mascagni injected his cadavers with mercury. Ever mobile, the mercury coursed through their veins like blood, illuminating …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.